Subtotal : ₹ 0.00
All Prod. (2972)
| Drug Code | Drug Name | Quantity | UOM Name | Batch No | Exp Date | Quantity | MRP |
|---|---|---|---|---|---|---|---|
| 405 | Ofloxacin Infusion IP 200 mg per 100 ml | 100 ml | -n/a- | 2027-04-16 | 4070 | 0 | |
| 405 | Ofloxacin Infusion IP 200 mg per 100 ml | 100 ml | -n/a- | 2027-04-16 | 4070 | 0 | |
| 409 | BENZYLPENICILLIN INJECTION IP 1.2 MILLION UNITS | Vial | -n/a- | 2027-04-16 | 1522 | 0 | |
| 409 | BENZYLPENICILLIN INJECTION IP 1.2 MILLION UNITS | Vial | -n/a- | 2027-04-16 | 1522 | 0 | |
| 411 | BEVACIZUMAB INJECTION 25 MG/ml | 1's | -n/a- | 2027-04-16 | 205 | 0 | |
| 411 | BEVACIZUMAB INJECTION 25 MG/ml | 1's | -n/a- | 2027-04-16 | 205 | 0 | |
| 412 | Azathioprine Tablets IP 50 mg | 10's | T3433 | 2026-12-31 | 60 | 45 | |
| 412 | Azathioprine Tablets IP 50 mg | 10's | T3433 | 2026-12-31 | 60 | 45 | |
| 413 | Methotrexate Tablets IP 7.5 mg | 10's | ST24-3200 | 2026-10-31 | 14730 | 25 | |
| 413 | Methotrexate Tablets IP 7.5 mg | 10's | ST24-3200 | 2026-10-31 | 14730 | 25 | |
| 413 | Methotrexate Tablets IP 7.5 mg | 10's | ST24-3200 | 2026-10-31 | 14730 | 25 | |
| 416 | Prazosin Tablets IP 5 mg | 15's | -n/a- | 2027-04-16 | 3430 | 0 | |
| 416 | Prazosin Tablets IP 5 mg | 15's | -n/a- | 2027-04-16 | 3430 | 0 | |
| 416 | Prazosin Tablets IP 5 mg | 15's | -n/a- | 2027-04-16 | 3430 | 0 | |
| 417 | Telmisartan 40mg and Amlodipine 5mg Tablets IP | 15's | PRT2501-113 | 2026-12-31 | 32890 | 24.2 | |
| 417 | Telmisartan 40mg and Amlodipine 5mg Tablets IP | 15's | PRT2501-113 | 2026-12-31 | 32890 | 24.2 | |
| 417 | Telmisartan 40mg and Amlodipine 5mg Tablets IP | 15's | PRT2501-113 | 2026-12-31 | 32890 | 24.2 | |
| 422 | Torasemide Tablets IP 10mg | 15's | PWOEB14 | 2026-09-30 | 710 | 17 | |
| 422 | Torasemide Tablets IP 10mg | 15's | PWOEB14 | 2026-09-30 | 710 | 17 | |
| 422 | Torasemide Tablets IP 10mg | 15's | PWOEB14 | 2026-09-30 | 710 | 17 | |
| 428 | Digoxin Tablets IP 0.25 mg | 10's | TD-2160011 | 2026-03-31 | 728 | 9 | |
| 428 | Digoxin Tablets IP 0.25 mg | 10's | TD-2160011 | 2026-03-31 | 728 | 9 | |
| 428 | Digoxin Tablets IP 0.25 mg | 10's | TD-2160011 | 2026-03-31 | 728 | 9 | |
| 429 | Atorvastatin 10mg and Fenofibrate 160mg Tablets IP | 15's | GT242396 | 2026-11-30 | 490 | 30 | |
| 429 | Atorvastatin 10mg and Fenofibrate 160mg Tablets IP | 15's | GT242396 | 2026-11-30 | 490 | 30 | |
| 430 | Amiodarone Tablets IP 200 mg | 10's | -n/a- | 2027-04-16 | 450 | 0 | |
| 430 | Amiodarone Tablets IP 200 mg | 10's | -n/a- | 2027-04-16 | 450 | 0 | |
| 432 | Olmesartan Medoxomil Tablets IP 40 mg | 10's | BP4223 | 2026-08-31 | 26280 | 36.3 | |
| 432 | Olmesartan Medoxomil Tablets IP 40 mg | 10's | BP4223 | 2026-08-31 | 26280 | 36.3 | |
| 432 | Olmesartan Medoxomil Tablets IP 40 mg | 10's | BP4223 | 2026-08-31 | 26280 | 36.3 | |
| 433 | Isosorbide Mononitrate Sustained Release Tablets 30 mg | 30's | -n/a- | 2027-04-16 | 270 | 0 | |
| 433 | Isosorbide Mononitrate Sustained Release Tablets 30 mg | 30's | -n/a- | 2027-04-16 | 270 | 0 | |
| 433 | Isosorbide Mononitrate Sustained Release Tablets 30 mg | 30's | -n/a- | 2027-04-16 | 270 | 0 | |
| 435 | Rosuvastatin 10mg and Fenofibrate 160mg Tablets IP | 10's | GT240939 | 2026-03-31 | 44420 | 34.1 | |
| 435 | Rosuvastatin 10mg and Fenofibrate 160mg Tablets IP | 10's | GT240939 | 2026-03-31 | 44420 | 34.1 | |
| 435 | Rosuvastatin 10mg and Fenofibrate 160mg Tablets IP | 10's | GT240939 | 2026-03-31 | 44420 | 34.1 | |
| 440 | Metoprolol 50mg (Prolonged release) and Amlodipine Besilate 5mg Tablets IP | 7's | UGT241104 | 2026-06-30 | 1100 | 11 | |
| 440 | Metoprolol 50mg (Prolonged release) and Amlodipine Besilate 5mg Tablets IP | 7's | UGT241104 | 2026-06-30 | 1100 | 11 | |
| 440 | Metoprolol 50mg (Prolonged release) and Amlodipine Besilate 5mg Tablets IP | 7's | UGT241104 | 2026-06-30 | 1100 | 11 | |
| 443 | Isosorbide Dinitrate Tablets IP 5 mg | 50's | SIDT1229 | 2026-08-31 | 6630 | 20 | |
| 443 | Isosorbide Dinitrate Tablets IP 5 mg | 50's | SIDT1229 | 2026-08-31 | 6630 | 20 | |
| 443 | Isosorbide Dinitrate Tablets IP 5 mg | 50's | SIDT1229 | 2026-08-31 | 6630 | 20 | |
| 446 | Amlodipine 5mg and Hydrochlorothiazide 12.5mg Tablets | 10's | MT244342 | 2026-11-30 | 40360 | 16.5 | |
| 446 | Amlodipine 5mg and Hydrochlorothiazide 12.5mg Tablets | 10's | MT244342 | 2026-11-30 | 40360 | 16.5 | |
| 447 | Moxonidine Tablets 0.3 mg | 10's | PWODY22 | 2026-09-30 | 3113 | 47 | |
| 447 | Moxonidine Tablets 0.3 mg | 10's | PWODY22 | 2026-09-30 | 3113 | 47 | |
| 447 | Moxonidine Tablets 0.3 mg | 10's | PWODY22 | 2026-09-30 | 3113 | 47 | |
| 458 | Labetalol Injection IP 5 mg per ml | 4 ml Ampoule | -n/a- | 2027-04-16 | 89 | 0 | |
| 458 | Labetalol Injection IP 5 mg per ml | 4 ml Ampoule | -n/a- | 2027-04-16 | 89 | 0 | |
| 458 | Labetalol Injection IP 5 mg per ml | 4 ml Ampoule | -n/a- | 2027-04-16 | 89 | 0 | |
| 462 | Betamethasone Valerate 0.12%w/w and Clioquinol 3%w/w Cream | 30 GM | -n/a- | 2027-04-16 | 56 | 0 | |
| 462 | Betamethasone Valerate 0.12%w/w and Clioquinol 3%w/w Cream | 30 GM | -n/a- | 2027-04-16 | 56 | 0 | |
| 463 | Mupirocin Ointment IP 2 % w/w | 5 gm | E628-92 | 2026-11-30 | 4290 | 50 | |
| 463 | Mupirocin Ointment IP 2 % w/w | 5 gm | E628-92 | 2026-11-30 | 4290 | 50 | |
| 463 | Mupirocin Ointment IP 2 % w/w | 5 gm | E628-92 | 2026-11-30 | 4290 | 50 | |
| 464 | DICYCLOMINE 10 MG + PARACETAMOL 325 MG + TRAMADOL 50 MG CAPSULES | 10's | -n/a- | 2027-04-16 | 801 | 0 | |
| 464 | DICYCLOMINE 10 MG + PARACETAMOL 325 MG + TRAMADOL 50 MG CAPSULES | 10's | -n/a- | 2027-04-16 | 801 | 0 | |
| 464 | DICYCLOMINE 10 MG + PARACETAMOL 325 MG + TRAMADOL 50 MG CAPSULES | 10's | -n/a- | 2027-04-16 | 801 | 0 | |
| 466 | Ursodeoxycholic Acid Tablets IP 300 mg | 10's | BP5031 | 2026-12-31 | 390 | 160.6 | |
| 466 | Ursodeoxycholic Acid Tablets IP 300 mg | 10's | BP5031 | 2026-12-31 | 390 | 160.6 | |
| 466 | Ursodeoxycholic Acid Tablets IP 300 mg | 10's | BP5031 | 2026-12-31 | 390 | 160.6 | |
| 467 | Dicyclomine Hydrochloride 10mg and Mefenamic Acid 250mg Tablets IP | 10's | STG24353 | 2026-11-30 | 490 | 13.2 | |
| 467 | Dicyclomine Hydrochloride 10mg and Mefenamic Acid 250mg Tablets IP | 10's | STG24353 | 2026-11-30 | 490 | 13.2 | |
| 467 | Dicyclomine Hydrochloride 10mg and Mefenamic Acid 250mg Tablets IP | 10's | STG24353 | 2026-11-30 | 490 | 13.2 | |
| 470 | Diastase and Pepsin Liquid | 200 ml | -n/a- | 2027-04-16 | 8605 | 0 | |
| 470 | Diastase and Pepsin Liquid | 200 ml | -n/a- | 2027-04-16 | 8605 | 0 | |
| 470 | Diastase and Pepsin Liquid | 200 ml | -n/a- | 2027-04-16 | 8605 | 0 | |
| 471 | Oxetacaine, Aluminium Hydroxide and Magnesium Hydroxide Suspension | 200 ml | -n/a- | 2027-04-16 | 114 | 0 | |
| 471 | Oxetacaine, Aluminium Hydroxide and Magnesium Hydroxide Suspension | 200 ml | -n/a- | 2027-04-16 | 114 | 0 | |
| 471 | Oxetacaine, Aluminium Hydroxide and Magnesium Hydroxide Suspension | 200 ml | -n/a- | 2027-04-16 | 114 | 0 | |
| 472 | Esomeprazole 40mg (Enteric-Coated) and Domperidone 30mg (Sustained Release) Capsules | 10's | RC-250203 | 2027-01-31 | 330 | 22 | |
| 472 | Esomeprazole 40mg (Enteric-Coated) and Domperidone 30mg (Sustained Release) Capsules | 10's | RC-250203 | 2027-01-31 | 330 | 22 | |
| 472 | Esomeprazole 40mg (Enteric-Coated) and Domperidone 30mg (Sustained Release) Capsules | 10's | RC-250203 | 2027-01-31 | 330 | 22 | |
| 473 | Pantoprazole 40mg (Enteric Coated) and Levosulpiride 75mg (Sustained Release) Capsules | 10's | GC250076 | 2026-12-31 | 22648 | 55 | |
| 473 | Pantoprazole 40mg (Enteric Coated) and Levosulpiride 75mg (Sustained Release) Capsules | 10's | GC250076 | 2026-12-31 | 22648 | 55 | |
| 473 | Pantoprazole 40mg (Enteric Coated) and Levosulpiride 75mg (Sustained Release) Capsules | 10's | GC250076 | 2026-12-31 | 22648 | 55 | |
| 481 | Rifaximin Tablets 400 mg | 10's | ST24-1008 | 2026-03-31 | 10 | 200 | |
| 481 | Rifaximin Tablets 400 mg | 10's | ST24-1008 | 2026-03-31 | 10 | 200 | |
| 481 | Rifaximin Tablets 400 mg | 10's | ST24-1008 | 2026-03-31 | 10 | 200 | |
| 482 | Rabeprazole 20mg (Enteric Coated) and Levosulpiride 75mg (Sustained Release) Capsules | 10's | PC30056 | 2025-10-31 | 1430 | 36 | |
| 482 | Rabeprazole 20mg (Enteric Coated) and Levosulpiride 75mg (Sustained Release) Capsules | 10's | PC30056 | 2025-10-31 | 1430 | 36 | |
| 482 | Rabeprazole 20mg (Enteric Coated) and Levosulpiride 75mg (Sustained Release) Capsules | 10's | PC30056 | 2025-10-31 | 1430 | 36 | |
| 483 | Loperamide Capsules IP 2 mg | 10's | Z24-328 | 2026-04-30 | 210 | 7.7 | |
| 483 | Loperamide Capsules IP 2 mg | 10's | Z24-328 | 2026-04-30 | 210 | 7.7 | |
| 483 | Loperamide Capsules IP 2 mg | 10's | Z24-328 | 2026-04-30 | 210 | 7.7 | |
| 484 | Esomeprazole Tablets IP 40 mg | 10's | MT244314 | 2026-12-31 | 630 | 20.9 | |
| 484 | Esomeprazole Tablets IP 40 mg | 10's | MT244314 | 2026-12-31 | 630 | 20.9 | |
| 484 | Esomeprazole Tablets IP 40 mg | 10's | MT244314 | 2026-12-31 | 630 | 20.9 | |
| 487 | Dicyclomine Hydrochloride 10mg and Activated Dimethicone 40mg per 5 ml Suspension | 30 ml | -n/a- | 2027-04-16 | 560 | 0 | |
| 487 | Dicyclomine Hydrochloride 10mg and Activated Dimethicone 40mg per 5 ml Suspension | 30 ml | -n/a- | 2027-04-16 | 560 | 0 | |
| 487 | Dicyclomine Hydrochloride 10mg and Activated Dimethicone 40mg per 5 ml Suspension | 30 ml | -n/a- | 2027-04-16 | 560 | 0 | |
| 494 | Ispaghula Husk IP | 100 GM | -n/a- | 2027-04-16 | 22990 | 0 | |
| 494 | Ispaghula Husk IP | 100 GM | -n/a- | 2027-04-16 | 22990 | 0 | |
| 494 | Ispaghula Husk IP | 100 GM | -n/a- | 2027-04-16 | 22990 | 0 | |
| 495 | Ferric Ammonium Citrate 160mg, Cyanocobalamin 7.5mcg and Folic Acid 0.5mg Syrup per 15ml | 200 ml | -n/a- | 2027-04-16 | 276 | 0 | |
| 495 | Ferric Ammonium Citrate 160mg, Cyanocobalamin 7.5mcg and Folic Acid 0.5mg Syrup per 15ml | 200 ml | -n/a- | 2027-04-16 | 276 | 0 | |
| 495 | Ferric Ammonium Citrate 160mg, Cyanocobalamin 7.5mcg and Folic Acid 0.5mg Syrup per 15ml | 200 ml | -n/a- | 2027-04-16 | 276 | 0 | |
| 501 | Betamethasone Sodium Phosphate Tablets IP 0.5 mg | 20's | -n/a- | 2027-04-16 | 1110 | 0 | |
| 501 | Betamethasone Sodium Phosphate Tablets IP 0.5 mg | 20's | -n/a- | 2027-04-16 | 1110 | 0 | |
| 504 | Nandrolone Decanoate Injection IP 25 mg per ml | 1 ml | NDA-08 | 2026-05-31 | 2050 | 20 |